PMID- 35317325 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220324 IS - 1948-5204 (Print) IS - 1948-5204 (Electronic) VI - 14 IP - 2 DP - 2022 Feb 15 TI - Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis. PG - 533-542 LID - 10.4251/wjgo.v14.i2.533 [doi] AB - BACKGROUND: Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is emerging as a complementary therapeutic approach for pancreatic solid masses. However, results of published data are difficult to interpret because of a retrospective design and small sample size. AIM: To systematically review data on EUS-RFA for solid lesions and to pool the results of the different experiences in order to provide more consistent evidence in terms of safety and efficacy. METHODS: A comprehensive systematic literature search on the main databases was performed to identify articles in which patients with pancreatic solid lesions underwent EUS-RFA. The primary outcomes were procedure-related adverse events (AEs) and mortality. Secondary outcomes were the technical success rate and the effects on primary tumor growth. Statistical analyses were performed using Stata version 14.0. RESULTS: In total, 14 studies were included, with 120 patients undergoing 153 ablations of 129 solid pancreatic lesions. The STARmed technology was used in seven studies, the Habib system in six studies, and the HybridTherm probe in one study. The pooled technical success rate was 99.0% (I (2): 25.82%). The pooled overall AE rate was 8.0% (I (2): 11.46%). Excluding mild AEs, the pooled rates of serious AEs was 1.0% (I (2): 0%). No mortality related to the procedure was reported. CONCLUSION: The present pooled analysis confirms the safety and feasibility of EUS-RFA. CI - (c)The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. FAU - Spadaccini, Marco AU - Spadaccini M AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Di Leo, Milena AU - Di Leo M AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Iannone, Andrea AU - Iannone A AD - Endoscopy Unit, Azienda Ospedale Policlinico, Bari 70124, Italy. FAU - von den Hoff, Daan AU - von den Hoff D AD - Endoscopy Unit, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands. FAU - Fugazza, Alessandro AU - Fugazza A AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Galtieri, Piera Alessia AU - Galtieri PA AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Pellegatta, Gaia AU - Pellegatta G AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Maselli, Roberta AU - Maselli R AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Anderloni, Andrea AU - Anderloni A AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Colombo, Matteo AU - Colombo M AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. FAU - Siersema, Peter D AU - Siersema PD AD - Endoscopy Unit, Radboud University Medical Center, Nijmegen 6525 GA, Netherlands. FAU - Carrara, Silvia AU - Carrara S AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. silvia.carrara@hunimed.eu. FAU - Repici, Alessandro AU - Repici A AD - Endoscopic Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy. LA - eng PT - Journal Article PL - China TA - World J Gastrointest Oncol JT - World journal of gastrointestinal oncology JID - 101532470 PMC - PMC8918998 OTO - NOTNLM OT - Cryotechnology OT - Endoscopic ultrasound OT - Habib OT - Neuroendocrine tumors OT - Pancreas OT - Pancreatic cancer COIS- Conflict-of-interest statement: All the authors declare that they have no competing interests related to the topic. EDAT- 2022/03/24 06:00 MHDA- 2022/03/24 06:01 PMCR- 2022/02/15 CRDT- 2022/03/23 05:12 PHST- 2021/02/22 00:00 [received] PHST- 2021/04/27 00:00 [revised] PHST- 2021/12/31 00:00 [accepted] PHST- 2022/03/23 05:12 [entrez] PHST- 2022/03/24 06:00 [pubmed] PHST- 2022/03/24 06:01 [medline] PHST- 2022/02/15 00:00 [pmc-release] AID - 10.4251/wjgo.v14.i2.533 [doi] PST - ppublish SO - World J Gastrointest Oncol. 2022 Feb 15;14(2):533-542. doi: 10.4251/wjgo.v14.i2.533.